Semaglutid , imiti ikomeye yo kugabanya ibiro no gucunga diyabete yo mu bwoko bwa 2, yabaye uburyo bwo kuvura buzwi. Hamwe namazina yikirango nka Wegovy, Ozempic, na Rybelsus, itanga inyungu zubuzima.
Muri iki kiganiro, uziga uburyo bwo kubona semaglutide, haba mubisuye imbonankubone, inama za telehealth, cyangwa farumasi kumurongo. Tuzashakisha inzira zose ziboneka kugirango tumenye ko ushobora kubona ubu buryo bwiza bwo kuvura.
Semaglutid yerekanye ko ari ingirakamaro mu kugabanya ibiro mu kugabanya ubushake bwo kurya, gutinda gusohora gastric, no kongera insuline. Izi nyungu ni ingirakamaro cyane cyane kubantu bafite BMI ya 30 cyangwa irenga, cyangwa abafite BMI ya 27 cyangwa irenga nabo bafite ubuzima bujyanye nubuzima nkumuvuduko ukabije wamaraso cyangwa diyabete yo mu bwoko bwa 2. Ubuvuzi bwa Clinical bwerekanye ko semaglutide ishobora gutuma igabanuka ryinshi ryibiro byumubiri kubarwayi muribi bipimo. Iyi miti ikora yigana imisemburo karemano ifasha kugabanya inzara nisukari yamaraso.
Semaglutid kandi nigikoresho cyingenzi mugucunga diyabete yo mu bwoko bwa 2. Imiti nka Ozempic na Rybelsus irimo semaglutide, ikora itera imbaraga za insuline muri pancreas no kunoza isukari mu maraso. Iyi miti kandi ifasha kugabanya ibyago byo kurwara umutima nimiyoboro y'amaraso kubarwayi ba diyabete. Nka GLP-1 reseptor agonist, semaglutide ifasha gutinda gusohora gastric, bigira uruhare mugutezimbere glucose no gucunga neza ibimenyetso bya diyabete yo mu bwoko bwa 2.
Izina ry'ikirango |
Gukoresha Ibanze |
Imiterere ya FDA |
Gukoresha Ibiro |
Wegovy |
Kugabanuka |
FDA yemewe kugabanya ibiro |
Yemerewe kugabanya ibiro |
Ozempic |
Ubwoko bwa 2 gucunga diyabete |
FDA yemewe na diyabete |
Off-label yo kugabanya ibiro |
Rybelsus |
Ubwoko bwa 2 gucunga diyabete |
FDA yemewe na diyabete |
Off-label yo kugabanya ibiro |
Semaglutid igurishwa mumazina menshi yikirango, buri kimwe gikora intego zitandukanye. Wegovy nikirangantego cyonyine cyakiriwe na FDA byumwihariko kugabanya ibiro. Ku rundi ruhande, Ozempic na Rybelsus zikoreshwa cyane cyane mu gucunga diyabete yo mu bwoko bwa 2 ariko akenshi zandikirwa hanze ya label yo kugabanya ibiro. Iyi miti yerekanye akamaro gakomeye mu kugabanya ibiro byumubiri no kugenzura isukari mu maraso, bigatuma iba iy'agaciro gakomeye ku barwayi bafite umubyibuho ukabije ndetse na diyabete yo mu bwoko bwa 2.
Kugira ngo wemererwe na Wegovy (semaglutide) kugira ngo agabanye ibiro, abarwayi bagomba kuba bujuje ibipimo ngenderwaho by’umubiri (BMI). Umuntu ku giti cye akeneye BMI ya 30 cyangwa irenga (ifatwa nkumubyibuho ukabije) cyangwa BMI ya 27 cyangwa irenga ifite ubuzima bujyanye nayo nka hypertension, diyabete yo mu bwoko bwa 2, cyangwa gusinzira apnea. Ubushakashatsi bwerekanye ko semaglutide ishobora kuvamo kugabanuka cyane, cyane cyane kubarwanira kugabanya ibiro binyuze muburyo gakondo bwonyine. Ubu buvuzi bwemejwe na FDA bwo gucunga ibiro kandi akenshi buhujwe nimirire myiza hamwe na siporo.
BMI |
Ibipimo byujuje ibisabwa |
30+ |
Yujuje ibyangombwa byo kugabanya ibiro (umubyibuho ukabije) |
27+ |
Yujuje ibisabwa niba ubuzima bumwe cyangwa bwinshi bujyanye nubuzima (urugero, hypertension, diyabete yo mu bwoko bwa 2) burahari |
Semaglutid nayo iteganijwe gucunga diyabete yo mu bwoko bwa 2. Abarwayi basuzumwe na diyabete yo mu bwoko bwa 2 bakeneye ubufasha mu kugenzura isukari mu maraso yabo barashobora kwemererwa gufata imiti nka Ozempic cyangwa Rybelsus, byombi birimo semaglutide. Ubuvuzi bufasha kunoza igenzura rya glycemic kandi bigabanya ibyago byo kurwara umutima.
Abarwayi bafite BMI ya 25 cyangwa irenga barashobora kwemererwa niyi miti, cyane cyane iyo kugabanya ibiro ari igice cyingenzi muri gahunda yo kuvura. Semaglutide irashobora gutuma insuline itanga umusaruro no gutinda kwa gastrica, bigatuma ikora neza mugucunga isukari yamaraso hamwe nuburemere.
Imiterere |
Abemerewe kuvurwa |
Ubwoko bwa 2 Diyabete |
Ozempic cyangwa Rybelsus (hamwe cyangwa udafite intego zo kugabanya ibiro) |
BMI 25+ |
Yujuje ibisabwa Ozempic cyangwa Rybelsus |
Rimwe na rimwe, abantu ntibashobora kubona ubucuruzi bwa semaglutide iboneka kubera gukenera cyangwa izindi mpamvu. Semaglutide ivanze, yakozwe na farumasi yihariye, irashobora kuba iyindi. Ariko, semaglutide ivanze ntabwo yemewe na FDA, kandi ubwiza bwayo nibikorwa birashobora gutandukana. Iyi miti isanzwe yandikiwe abantu bakeneye ibipimo byihariye cyangwa bafite sensitivité verisiyo isanzwe yubucuruzi idakemura.
Nubwo semaglutide ivanze itanga ibintu byoroshye, itwara ibyago byinshi, harimo kwanduza, ibipimo bitari byo, no kubura kugenzura. Abarwayi batekereza semaglutide ikomatanyije bagomba kuganira ku ngaruka n’inyungu hamwe n’ushinzwe ubuzima mbere yo gukomeza.
Kubona semaglutide, haba kugabanya ibiro cyangwa gucunga diyabete yo mu bwoko bwa 2, ikurikira inzira isobanutse. Urashobora kugera kuri semaglutide ukoresheje inama-yumuntu, serivisi za telehealth, cyangwa guhuza byombi. Hano haribintu byimbitse reba intambwe zirimo kubona imiti ya semaglutide.
Intambwe yambere yo kubona semaglutide ni uguteganya gusura hamwe nubuvuzi. Mugihe cyo kugisha inama umuntu, umuganga azasuzuma amateka yubuzima bwawe, imiti iriho, nintego zo kuvura. Bazasuzuma niba semaglutide ikwiye ukurikije uko umeze - haba mu gucunga ibiro cyangwa isukari mu maraso. Nyuma yo gusuzuma amakuru yawe yubuvuzi no kumenya ko wemerewe, utanga ubuvuzi azandika imiti ya semaglutide.
Gusura kumuntu bitanga inyungu zubuvuzi butaziguye, bwuzuye, aho uwaguhaye serivisi ashobora gusuzuma ubuzima bwawe kandi agakemura neza ibibazo byose. Izi nama zikurikirwa no koherezwa muri farumasi aho ushobora kubona imiti yabugenewe.
Serivise za telehealth zahindutse inzira izwi kandi yoroshye yo kubona semaglutide. Abatanga ubuvuzi benshi ubu batanga inama kumurongo, byorohereza abarwayi kubona imiti nka semaglutide batavuye munzu zabo.
Mugihe cyo kubonana na telehealth, uzuza urupapuro rwo gufata imiti kandi birashoboka kohereza ibisubizo bya laboratoire. Nyuma yo gusuzuma uko ubuzima bwawe bumeze hamwe nubuvuzi bukenewe, utanga ubuvuzi azaguha semaglutide niba wujuje ibyangombwa bikenewe byubuvuzi. Telehealth nuburyo bwiza kandi bworoshye kubantu bakunda ubuvuzi busanzwe cyangwa bafite ikibazo cyo guteganya gahunda zabo.
Waba wahisemo gusura umuntu cyangwa kugisha inama kuri telehealth, ibizamini bya laboratoire hamwe nisuzuma ryubuzima birashobora gusabwa kugirango semaglutide ikwiranye nubuzima bwawe. Ibi bizamini mubisanzwe bikubiyemo gukurikirana isukari mu maraso, imikorere yimpyiko, nubuzima rusange bwa metabolike. Kurugero, niba urimo kwandikirwa semaglutide ya diyabete yo mu bwoko bwa 2, umuganga arashobora gukora ibizamini kugirango asuzume uburyo umubiri wawe ucunga glucose.
Byongeye kandi, imikorere yimpyiko nubuzima bwa tiroyide irakurikiranwa, kuko semaglutide ishobora kugira ingaruka kuri izi ngingo. Ibizamini bya laboratoire bifasha kwemeza ko semaglutide ari umuti wizewe kandi mwiza kuri wewe, ukemeza ko imiti izaba ingirakamaro kandi yihanganira.
Ubwoko bw'ikizamini |
Intego |
Urwego rw'isukari mu maraso |
Kugirango usuzume ibyangombwa byandikiwe na diyabete |
Imikorere y'impyiko |
Iremeza gukoresha neza semaglutide, cyane cyane kubikoresha igihe kirekire |
Ubuzima bwa Thyroid |
Ni ngombwa kubarwayi bakoresha semaglutide kugirango birinde ibibazo bya tiroyide |
Kugura semaglutide kumurongo birashobora kuba amahitamo yoroshye, cyane cyane kubadashoboye gusura umuganga wubuzima imbonankubone. Nyamara, ni ngombwa kwemeza ko ugura isoko izwi kugirango wizere umutekano nukuri kwimiti. Dore ibyo ugomba kumenya mbere yo kugura semaglutide kumurongo.
Hano hari urubuga rwizewe rwa interineti aho ushobora kugura semaglutide, ariko ni ngombwa kwemeza ko farumasi wahisemo yemewe kandi ikurikiza amahame ya FDA. Farumasi zimwe zo kumurongo, nka Noom na LifeMD, zitanga inama za telehealth, aho abashinzwe ubuzima basuzuma ubuzima bwawe kandi bagatanga semaglutide niba bibaye ngombwa. Izi porogaramu ziragenzurwa, kandi zemeza ko wakiriye imiti ikwiye hamwe nubuvuzi bukwiye.
Mbere yo kugura muri farumasi iyo ari yo yose yo kuri interineti, banza urebe ko babifitemo uruhushya hanyuma ubaze niba farumasi yanditswe mu nzego za leta cyangwa z'igihugu. Ibi byemeza ko imiti wakiriye ari iyukuri kandi yujuje ubuziranenge. Ibibuga byinshi byemewe bitanga inama kubuntu kandi byizewe.
Ihuriro |
Serivisi |
Imiterere |
Noom |
Ifishi yo gufata imiti kumurongo, gahunda yo kugabanya ibiro |
Utanga ubuvuzi bwemewe |
UbuzimaMD |
Kugabanya ibiro, kugisha inama telehealth |
Utanga ubuvuzi bwemewe |
Hers |
Kwiyongera kwa semaglutide, gahunda yo kwiyandikisha |
Farumasi yanditswe |
Mugihe kugura semaglutide kumurongo bitanga ibyoroshye, kugura amasoko atagengwa byerekana ingaruka zikomeye. Farumasi zimwe zo kumurongo zirashobora kugurisha imiti yimpimbano cyangwa semaglutide ivanze idahuye nubuziranenge bwumutekano wa FDA. Ibi birashobora gushikana ku ngaruka mbi, nko kunywa nabi, umwanda, cyangwa kuvura bidafite ingaruka.
Inkomoko itagengwa na kenshi ntabwo isaba imiti, ibyo bikaba byongera amahirwe yo kwakira ibicuruzwa biteje akaga cyangwa bidafite gihamya. Byongeye kandi, semaglutide yimpimbano irashobora gukurura ingaruka nkumubabaro wa gastrointestinal, ibibazo byumutima nimiyoboro, ndetse nibibazo byangiza ubuzima.
Kugira ngo wirinde izo ngaruka, buri gihe urebe ko farumasi yo kuri interineti isaba imiti yemewe n’ubuvuzi bwemewe kandi ikurikiza ibipimo ngenderwaho byose.
Umaze kwakira inyandiko, urashobora guhitamo kugemura murugo. Witondere kubaza ibihe byo kubyara kandi urebe ko imiti iva mubyemezo byemewe, byemejwe.
Izina ry'ikirango |
Igiciro (Kwezi) |
Impuzandengo |
Wegovy |
$ 1,400 |
2.4 mg |
Ozempic |
$ 1.000 |
2 mg (buri cyumweru) |
Rybelsus |
$ 972 |
3 mg (buri munsi) |
Imiti ya Semaglutid nka Wegovy na Ozempic irashobora kugura hagati y $ 1.000 na 2000 $ buri kwezi, ukurikije ikirango na dosiye. Kugura hirya no hino no gukoresha urubuga rwo kugabanya birashobora gufasha kugabanya ibi biciro.
Amasosiyete menshi yubwishingizi ntabwo apfukirana semaglutide kugirango agabanye ibiro. Ariko, barashobora kubipfukirana mugucunga diyabete. Nibyingenzi kugenzura hamwe nabashinzwe gutanga ubwishingizi kugirango urebe niba semaglutide yandikiwe.
Porogaramu nka gahunda yo kuzigama ya Novo Nordisk irashobora gutanga kugabanuka, bigatuma semaglutide ihendutse kubarwayi badafite ubwishingizi.
Semaglutide irashobora gutera gastrointestinal ingaruka mbi nko kugira isesemi, kuruka, no gucibwamo. Ibi mubisanzwe bigabanuka uko umubiri umenyera.
Semaglutid irashobora gukurura ibibazo bikomeye nka pancreatitis, ibibazo byimpyiko, nibibyimba bya tiroyide. Abarwayi bagomba kuganira n’izi ngaruka n’ubuvuzi bwabo.
Abantu bafite amateka ya kanseri ya tiroyide, pancreatite, cyangwa ibibazo byimpyiko bagomba kwirinda semaglutide. Abagore batwite cyangwa abagerageza gusama nabo bagomba kwirinda gukoresha ibiyobyabwenge.
Ubundi buryo bwa semaglutide burimo indi miti ya GLP-1 nka liraglutide (Saxenda) na dulaglutide (Trulicity), ishobora no gufasha kugabanya ibiro no kurwanya isukari mu maraso.
Guhindura imibereho nko guhindura imirire no gukora siporo bigomba guhora biherekeza imiti iyo ari yo yose. Ubu buryo butari ibiyobyabwenge burashobora gufasha kuzamura imikorere yimiti nka semaglutide.
Semaglutid irashobora kugira uruhare runini mugucunga ibiro cyangwa diyabete, ariko kuyibona bisaba kubahiriza ibipimo byihariye. Haba binyuze mu gusura umuntu ku giti cye, kugisha inama telehealth, cyangwa farumasi zo kuri interineti, ni ngombwa kwemeza umutekano kandi byemewe n'amategeko. Buri gihe ujye ubaza abashinzwe ubuzima kugirango umenye uburyo bwiza ukeneye kubuzima bwawe.
Cocer Peptides ™ itanga ibicuruzwa byingirakamaro bifasha abantu kubona semaglutide muburyo bwizewe, bwizewe, byongera ibiro byabo hamwe nurugendo rwo kuyobora diyabete.
Igisubizo: Semaglutid ni GLP-1 yakira reseptor agonist ifasha mukugabanya ibiro mukugabanya ubushake bwo kurya no kunoza insuline.
Igisubizo: Urashobora kubona semaglutide ukoresheje ubuvuzi, inama za telehealth, cyangwa farumasi zizwi kumurongo.
Igisubizo: Urashobora kwemererwa na semaglutide niba wujuje ibipimo bya BMI cyangwa ufite ubuzima bujyanye nuburemere nka diyabete.
Igisubizo: Kugura semaglutide kumurongo birashobora kuba umutekano mugihe uhisemo farumasi yemewe kandi igenzurwa bisaba imiti.
Igisubizo: Igiciro cya semaglutide kiratandukanye, ibiciro biri hagati y $ 972 kugeza $ 1,400 buri kwezi bitewe nikirango na dosiye.
Igisubizo: Yego, urashobora kubona semaglutide ukoresheje gahunda zifasha abarwayi cyangwa kwishyura amafaranga atavuye mumufuka.
